← SynDRA
NARATRIPTAN
SynDRA canonical compound SYN0005001 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HTR1A | HTR1B | HTR1D | HTR1E | HTR1F |
| Mechanism of action | serotonin receptor agonist |
| Indication | migraine headache |
| Disease area | neurology/psychiatry |
All known targets
- HTR1B
- HTR1D
- HTR1A
- HTR1E
- HTR1F
Mechanisms of action (all sources)
- HTR1B AGONIST
- Serotonin 1b (5-HT1b) receptor agonist
- HTR1D AGONIST
- Serotonin 1d (5-HT1d) receptor agonist
- HTR1A FULL AGONIST
- HTR1B PARTIAL AGONIST
- HTR1D FULL AGONIST
- HTR1E FULL AGONIST
- HTR1F FULL AGONIST
- serotonin receptor agonist
Drug classes
- Cardiovascular Agents
- Neurotransmitter Agents
- Serotonin 5-HT1 Receptor Agonists
- Serotonin Agents
- Serotonin Receptor Agonists
- Vasoconstrictor Agents
- Serotonin 1b Receptor Agonists
- Serotonin 1d Receptor Agonists
- Serotonin-1b and Serotonin-1d Receptor Agonist
ATC classes
- N02C · ANTIMIGRAINE PREPARATIONS
Cross-references
Synonyms
- naratriptan hydrochloride
- naratriptan HCl
- Colatan
- Naramig
- Naratriptanum
- Amerge (TN)
- Naramig (TN)
- Naratriptan (INN)
- Amerge, Naramig,Naratriptan
- N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide
- N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
- N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide
- QX3KXL1ZA2
- naratriptanum
- CHEBI:7478
- RefChem:57988
- DTXCID003354
- N02CC02
- NARATRIPTAN [INN]
- NCGC00181786-01
- Naratriptan [INN:BAN]
- UNII-QX3KXL1ZA2
- NARATRIPTAN [MI]
- GTPL45
- NARATRIPTAN [VANDF]
- SCHEMBL68753
- NARATRIPTAN [WHO-DD]
- BIDD:GT0312
- orb1298731
- SCHEMBL29403931
- NARATRIPTAN [ORANGE BOOK]
- HY-B0197
- BDBM50073682
- EBC-26632
- MFCD00866221
- AKOS015895854
- AC-5013
- NCGC00181786-03
Reported adverse events
- Hypersensitivity
- Malaise
- Nausea
- Arrhythmia
- Dizziness
- Pain
- Serotonin syndrome
- Medication overuse headache
- Fatigue
Look up NARATRIPTAN in the interactive SynDRA portal →